VASP immunoreactivity was negative in 7 CRC cases (−, 11%), weakly positive in 22 cases (+, 35%), high in 23 cases (++, 36%), and very high in 11 cases (+++, 18%) (Fig. 1a). This evidence concerns the gene VASP and colorectal carcinoma.